Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Spruce Biosciences Inc
(NQ:
SPRB
)
0.7000
-0.0010 (-0.14%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Apr 26, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Price and Volume
Detailed Quote
Volume
211,577
Open
0.7100
Bid (Size)
0.7000 (85)
Ask (Size)
0.7088 (60)
Prev. Close
0.7010
Today's Range
0.6977 - 0.7101
52wk Range
0.6711 - 5.950
Shares Outstanding
40,710,692
Dividend Yield
N/A
Intraday
1 Week
1 Month
3 Month
1 Year
3 Year
5 Year
Top News
More News
Spruce Biosciences Announces Upcoming Poster Presentation at the Pediatric Endocrine Society 2024 Annual Meeting
April 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 21, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Performance
YTD
-76.35%
-76.35%
1 Month
-5.41%
-5.41%
3 Month
-79.41%
-79.41%
6 Month
-32.69%
-32.69%
1 Year
-66.35%
-66.35%
More News
Read More
Spruce Biosciences' Hormone Treatment Stumbles In Trials, Prompts Stock Freefall
March 14, 2024
Via
Benzinga
Spruce Biosciences, Inc. (SPRB) Investigation: Bronstein, Gewirtz & Grossman, LLC Encourages Investors to Seek Compensation for Alleged Wrongdoings
March 14, 2024
From
Bronstein, Gewirtz & Grossman, LLC
Via
Business Wire
Dow Dips Over 100 Points; Dick's Sporting Goods Earnings Top Views
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
12 Health Care Stocks Moving In Thursday's Intraday Session
March 14, 2024
Via
Benzinga
Crude Oil Moves Higher; Dollar General Posts Upbeat Earnings
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
Fossil Fuels
US Equities
Why Limbach Holdings Shares Are Trading Lower By Around 15%? Here Are Other Stocks Moving In Thursday's Mid-Day Session
March 14, 2024
Via
Benzinga
US Stocks Higher; Producer Prices Rise 0.6% In February
March 14, 2024
Via
Benzinga
Topics
Stocks
Exposures
US Equities
Is Altria Giving Up on Anheuser-Busch (BUD) Stock?
March 14, 2024
Via
InvestorPlace
Why Is Rare Endocrine Disorder-Focused Spruce Biosciences Stock Plummeting On Thursday?
March 14, 2024
Via
Benzinga
12 Health Care Stocks Moving In Thursday's Pre-Market Session
March 14, 2024
Via
Benzinga
Why Is Fisker (FSR) Stock Down 41% Today?
March 14, 2024
Via
InvestorPlace
Why Is Spruce Biosciences (SPRB) Stock Down 78% Today?
March 14, 2024
Via
InvestorPlace
Why Robinhood Shares Are Trading Higher By Around 12%; Here Are 20 Stocks Moving Premarket
March 14, 2024
Via
Benzinga
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Thursday
March 14, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Wednesday's After-Market Session
March 13, 2024
Via
Benzinga
Spruce Biosciences Reports Full Year 2023 Financial Results and Provides Corporate Updates
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Announces Topline Results from CAHmelia-203 in Adult Classic CAH and CAHptain-205 in Pediatric Classic CAH
March 13, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Tuesday
February 13, 2024
Via
InvestorPlace
12 Health Care Stocks Moving In Tuesday's After-Market Session
January 30, 2024
Via
Benzinga
Spruce Biosciences to Present at the Oppenheimer 34th Annual Healthcare Life Sciences Conference
January 30, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Completes Enrollment in CAHmelia-204 Study for Adult Classic Congenital Adrenal Hyperplasia
January 22, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Reports Baseline Characteristics from CAHmelia-203 and CAHmelia-204 Studies in Adult Classic CAH
January 05, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Spruce Biosciences Provides Clinical Program Updates and Outlook for 2024
January 04, 2024
From
Spruce Biosciences, Inc.
Via
Business Wire
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.